2
A-4
4-- ~A--~--44-~--~- 4-- - - -~ -~ -4~ -~ -- -~ -~Table 1.
Types of
opioid
receptors and their
activity*
Receptor
Activity
mu-1
Supraspinal analgesia
Prolactin release
Catalepsy
Cardiovascular effects
Miosis
Physical dependence
Indifference to environmental stimulus
mu-2
Respiratory depression
Dopamine turnover
Feeding
Cardiovascular effects
Possible growth hormone release
Delta
Modulate mu receptor activity
Spinal analgesia
Dopamine turnover
Possible growth hormone release
Kappa
Spinal analgesia
Inhibit antidiuretic hormone release
Sedation
Miosis
Possible respiratory depression
Dysphoria
Sigmat
Dysphoria
Hallucinations
Hypertonia
*Other
opioid subtypes exist, such as kappa-1, kappa-2, and
kappa-3. Each receptor subtype may be associated with
dis-tinct effects. Much of our knowledge of receptor subtypes
comes from work performed on nonhuman species.
tBinding to the sigma receptor is not antagonized by
nalox-one. Furthermore, in light of the kappa-mediated dysphoria,
many authorities no longer consider the sigma receptor as
an opiate receptor.
Table 2.
Characteristics of addiction
* Use of a drug in excessively high amounts or for a
time longer than intended
* Intoxication not uncommon, symptoms of
with-drawal when not administered
* Drug limits personal or work schedule
* Use of drug persists despite work-related or
per-sonal health-related problems
* Large amount of time and resources used to obtain
the drug
* Lack of success in attempts to reduce the use of
the drug
* Evidence of diminishing effect of a given dose
(tolerance)
* Use of the drug specifically to avoid the symptoms
of withdrawal
Table 3.
Comorbid conditions often observed in
the person addicted to opioids
Malnutrition
Hepatitis
Acquired immune deficiency syndrome*
Tetanus
Endocarditis
Pulmonary embolization and infarction
Superficial skin abscesses and infections
Cellulitis
Thrombophlebitis and septic thrombophlebitis
Adrenal gland dysfunction
Positive serologic test results
Aspiration pneumonitis
Cigarette abuse with chronic obstructive lung disease
Ventilation-perfusion mismatch
*There is no specific or documented increased risk of
anes-thesia for patients with the acquired immune deficiency
syn-drome. However anesthesia-related risk in the presence of
human immunodeficiency virus has not been well studied,
and any conclusions are premature at best.
i n ti {Choi to . L.. though the
.li
time tnf fence C4; hid dii ti repetitiontaking, the pers lc :theta bi ter tai p 4 au tauswn
control its
use.
Compulsive, over a 4LL_. ,tremors
, dx ra'voluntary use of the oproid
OOMM
i t +ctale na ea can.,Claim
they
-lcae' tddir pain control
during
:a pre4ios,.Although some biological ch ge i t ificat i _ r provide
vau
wised°xs rtu xt d al fray a i6id-de nden state
sothat
single analgesic dose-of morphi ,1 . .z. .... p
-w
p
t
is .. ,, 1,.
"'Ally
no evidence that p roprxa severity the wxthdra alsymptoms
and their= v i t a l use of opioids to .relieve .} w: at d med ' compli o s are- m r zed,
;addiction. d all r,,a ch rams offer
follow -UP
to minimizethe rte mid of relapse
MUdrawax
A traditions! form of 'pharmacologicalassisted
Ian -addicted person f ni the ; r nth mplisfied with' the use of
me
AI
h
fl .,rive drug will precipitate a
+n
dra
l syridr
a s
66e
deter fi tzntx. l rt thx apps Y a lon :acting"' th
another.
wa
synd Bar, xn vod idid thj at herox ri idinefor
or a shorter th' . acts:.':e=0% MP.
s, p pe o er prhol, and opioids.ea
h have
t 'r ch erish soron
op o d), and the dose is aduaily tay mot'tb traw of syn A ry; z ed. Methadone is marketed under the grade
Our percepts name Dolophine and has a plasma half-life
of
ap-gar. h may= roximately
'30
he tors. Long-term success ratesmedia'represetttat1on Curd- s. Y seem quite va i ble- rith conventional approaches;
calla ,the with I 1 po
, , rt success rates are
low
and. dropout ratesv y
severe
h5'4 *14;
q rte hh.l
Interpretation of these reports: mustn a ona txc . k o .ledge often ark>an dam ;: involve:
jar MC" TMU
131"Wal
,, : "m ,gi p aIgnMont d_ l zg .yexperience treating .addic " their ,Sub* it rns of s ess..
aer pl n t t 14 is akin t, o-a a l eth rlt .a ethad a der
t, ache with unreient 4-gi n 1 a tive# was approved for use'in the United States
p .
t
# '= . ,v
ngr ma f ilk th r.
ethadone t ass{an
alterna
n$anal account tV rdte: tive to ethadone and
dict''is,'acute aware oaf 'his sur lie adm n inter d on alternate days, which. may
pro :ate at it
y
'xnpvtng-+d to Vie: an att tive.alternative
pe6o
s eexn, .r a#io n. Famjlia.r, alxjeelIi anc ,
Ex
rien with the drug xs growxng, .al,:Hof
W
sign ficant n urea' nd even resp rat ory der\qA f s ions ex l , ~ 4 on art :associated
with
its use(:Gil
Fanciullo.stelf , d t ,PaainC1iaic, rtmouth .H hcock
luenced ' the c edical-Center, persoual.communication,
aver-b s try; ore ece .d a P1*brup} C .7 tQ t me J. , ch
lr. \ s 11 \ 1 $ 1 1 I^ ' l i "*"A lfi+';T+ l j .7 'ti7ll
cr*vixtg mire
.*:rapid
or ult pi l detoxification hashe
pic-11 \I
a _ p1tl t erg arnoted' usingapjoid antagoni is such as naloxane
o + altr cane: e oa is ra detc .. xu eat, g p ication tc
le, fb s cxcc rs
et
generally.:rip
xn 4 " . k n , .. , Iles.x
minimize' u off the topportunitY
one for tuaintenanc
for relypse, continued e, and appro-IV
-cen i t I prigte psyche follvwTup. Genera! anesthesia,
Tie . opioi de e e e cif ry deep sedation, inc rpo rated
drr -enga in a i 1 app a es to make' the patient
insensi-r ho i almost'nl ys ' a 4 ,; a Ir h xtn:the vie v intoleralrl e sympto s a.
aci-ti of the'; cravin h .gat :w ica 't or ul tra p
id
d, tc adfiea ion.. Inthe
ff
the
craving canto nce ofopoid
addiction, theadministration
l our ure val p
an-
acute w drawalqA.
~
1?c w ..i Y '44 !{r ' P .4-3
Y Y'3
4y 444 r 44, 4.3 s i { to. p4.q, Aandeffiacy , rpor. ofs g
offieg~~~~~~~.44' n'ee!2cse t fdahi h
T 4 Luoet.exe .,exeniv
r.wk-'S iF
a
d
ened oron ig4444;y
an4 eore 444444-'ono4adKot
44d o4 :
~
444"4 a ayiso p4otera 1suisaalbeo 4)4444.t 4te
4rl
d4aetei4prah s, el~ihrpe poddtxfc
prpahes prod ten' tobe' ighl siis te sytemaic aa4y4s o
spt .' um "o to nt . o aieyo niiul tde o h 4444
we~~~~~~~~~~~~~~~~~~~44 i4. h' enonee - reitnet f-qatttv ytei.Atog h
F s f .It a-paticuar tha appva A,.xRUbe ticzedon ertan mt dlog
4eea ans4444e4o4.44 {ob. i i xi aual ndacpedwyt
with~~~~~~~~~'44 efoeti 4tpfl hoetl ' 'ieoto ru fsuista
lam,~~~~~ or~4444~, a"4 poe
4
thadoa4
s . f' 4 n"thmeorpupoe
tend,
4 to las 30t. 40miues it4444d44444,4r stou t ss te vdec
r he s intu cammo ati estfor n ap arenly of u d toxiicaton ppr4ches 44
way maaeet
444',poddp nce hy ie
Afte~th 'ai r~tptdetxificaionora de ntl theappoac be
on is precrbe fo eea ots n te r;atni
,s
hteiaca n rtint uneg444n scoaia ne~etoti h ae osdrn pod
However,~~ it
~
t p ns netrdcd 4saprn4rmte4tfrm ifraio ,4ot,.. l e rm pra e
sie thtntalo4h ramatcnes ef $ e~a se erhd ELN o
44 !
eqipd-opoieth 44'aa seta tr rm 96t 97ta
folwu 44 /744444ne444 :N4 44 rapi
-assisted4
4.4444 44,444.444,,4 4. J2~
S4 eniig(n4pprnl4omrktbe44 " , q b ecnq;te 4 and'' 2. '.
4'44ofthsep44m tha fo444r4 th 44ds44
k4
1,
IsubWIV
rap*a
ap44,44 in seece Amr4a 4e ppr,:n t4444 4444 nsTheclinicl featues444o
tre.men cen4444 ar41evl rmtd n l ., e nldn eondp
Inent At4 cot4f$,0,ndmr vdr4y ,eedne ddcint e
covered by4 trdiioa healt inua4 444/4 or4, '4 d44 varou cobntoso e
4 ai,4ter is 4nc cocr abou th .4a44, 44,4.44.4 . ers halh cndiio, cdepn
tance hrpui
~
~
~
prah-ht~
~
of444 4~44,4444.44~4 a ntlicnii a4oe fteptetbeen subjected4 4 to4444444 rigorou scintficanlyis.th rpors.Geera ase
'The4 4nere is wel rereened b 44 4444444~it 444 4 4sedation
of44444444 deoiiaio etr ta"uehghy tlze)4h4pciioos eed1,
makein aprace
v444
a4
specific We sites.444444r r
y a 4 ' a ' e
duced
tno
systeai c, parosetv fahocol
omnl
o?
raabrp
econfcluions We
dn.
'onrad
qie
u
Koster nte
th
e
ntue
o
e
thrpe
rase
"
bso~t
:
oioid
ndetoxictro
hertion
.
Ther is~i~x
no~~ct
thrlle
inn
af abiopt
withdrawal
pb
cmAredsthi thier
lieywlthaioe
my nraeth iko brp ihr
rabotchs aproach n
thee
a4 fuueo
ate
fceo nshtcaets Smlry hr
abth rpd etoxificatin Whe fruin
ana-
cr h
rcs.Fr
xmlaetei
rv
proh to tffeste, ain ts several
ecavasshudb
esaeawr
ihrwa rmseaie
kpoft incemid:
etais
hypnoticse
isaptnilmdia
mre
n
styandn cntoer e is oeuting~t tvde tha
n
htthbikesoiae
ihte otne s
the
time of pioid wire
awstald
can
e
otnd
fopisjuiythrsk'of
geeahaetesa
ppaces.Frterore , heis
me
vdee
that~
qut larta h daai
crivsulrcn
ia
efetiean
d~ prhaseo~oially fesbepeoiiatorei
h
otiuu
rsnet
profit~
inetie t estbihtetetcnes re
tdredetof
reuionpeeveotomsrpr-
eeaeddtxfcainapoahspr
tipl
at
payerare acc~ustomed. Becs
e
fte
ceryrpeeta
noaieadpsil
po
hpretaynture~
ofteetetetcnesNhr
sn
ppiaino
hraooialasse
is
a
hereacyt
shae prtcl
n
Nrcdrlpodwtdaa.Te
oet
fteapoc
infmain
antboeemhszd4n
hene.-oae
3.~~
~
~
It htteascae ha enage rc- flycnrle tde oeaut fiay aeyducal~~~~~~~~~~~~~~~~K' rNncepalNie rik hepsil a- n otms b cnwegd
-G
~
- . n,~ .y--tbi
~
:~ r:1 r 44~
"4'' rf f + x. ., 'CAr y W tar' $ ii-;;f o. h . c+ w^ j ( .7t.M'' r\ a" $ ' y d .fis
eto tl I
V
ntz.:x
+T''re9L^+s .zS~ r. r' r ,a k '+ r D
~
of\. fe
~
i r:~
t I .tA~4 \~' ..
~
-~~
~
-~k\\~Y~
(7)~ Are
~~~~~~~~~k
~
RP ace, ad~ftn.',k *ttre \44.if .t d9)
et ebt
S-p~no
.$v
udde -%4 anethesa..JAMA1997277:
(10
~
Ulr-a B rawer~~~~~~~ tttWoit pat eoi U C. pd H R~-
-oprbns
tion under. -4-- al anshei or se aton Ad ---ic Bis ;:91
(11)
~
~ ~ ~
~
ntaai~
~
podd~xf-Knehl~
~
~
P-~
~
~ ~ ~ ~ ~
< -DCar~o -itnT.RpdHas . e N
c t
~us
-e .I ;7:924lxtoA
(12 San L, Pui M , Bu b n ,-re M H gh rs f ut m t
Cruises
Tours
Family
Vacations
Honey.moons
Ivel
222 South Prospect Avenue Park Ridge, IL * 60068-4001